Lobe Sciences (LOBEF) Stock Price, Quote, News & History

Lobe Sciences Ltd (LOBEF) Stock Price, Quote, News & History

LOBEFOTCQB

Trade with Public

$0.0511

0.004529.70%

At close: Apr 2, 5:00 PM EST

Key Statistics

Open

$0.05

Volume / Avg.

2.54K / 105.32K

Day Range

$0.05 - $0.05

52 Wk Range

0.02 - 0.08

Market Cap

$13.78M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Lobe Sciences Ltd News

Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More

World's Largest Psychedelics Conference Boasts 12K Attendees

Lara Goldstein

This Biotech Is Entering The Clinical Stage With A Psilocin Analog Targeting Cluster Headaches

Lobe Sciences Ltd. (OTCQB: LOBEF), a biopharmaceutical company focused on non-hallucinatory doses of stabilized psychedelic-based compounds to treat rare diseases, has commenced its Phase 1 clinical study on proprietary psilocin analog L-130.

Lara Goldstein

Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More

LSD Trial Study Shows Potential For Major Depression Psychedelics biopharma company Mind Medicine Inc. (NASDAQ: MNMD) recently shared positive topline data from an advanced clinical trial of LSD as a treatment of Major Depressive Disorder (MDD).

Lara Goldstein

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-1.75M

Investing Cash Flow (TTM)

-1.03M

Financing Cash Flow (TTM)

8.81M

Free Cash Flow (TTM)

-1.75M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

6.03M

Valuation Metrics

Enterprise Value

$9.72M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

11.24

Earnings Yield % (TTM)

-61.73%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.00

Company Debt

Total Debt

$295.68K

LT Debt

$295.68K

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$5.99M

Debt to Equity

0.19

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.05

Volume / Avg.

2.54K / 105.32K

Day Range

$0.05 - $0.05

52 Wk Range

0.02 - 0.08

Market Cap

$13.78M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

N/A

Industry

N/A

Lobe Sciences Ltd is a biopharmaceutical company focused on using lipid technology that develop therapies for orphan and rare diseases. It commercializes Altemia MF, a medical food intended to address nutritional deficiencies associated with sickle c...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Lobe Sciences (LOBEF) stock?

You can purchase shares of Lobe Sciences (OTCQB:LOBEF) through any online brokerage.

View our list of the best stock brokerages

Who are Lobe Sciences (LOBEF) competitors?

There are no as such competitors for Lobe Sciences.

What is the forecast, or price target, for Lobe Sciences (LOBEF) stock?

There is no analysis for Lobe Sciences to provide a consensus price target.

What is the current price for Lobe Sciences (LOBEF)?

The stock price for Lobe Sciences (OTCQB: LOBEF) is $0.05112 last updated April 2, 2026 at 12:37 PM EDT.

Does Lobe Sciences (LOBEF) pay a dividend?

There are no upcoming dividends for Lobe Sciences.

When is Lobe Sciences (OTCQB:LOBEF) reporting earnings?

Lobe Sciences does not have any upcoming earnings scheduled.

Is Lobe Sciences (LOBEF) going to split?

There is no upcoming split for Lobe Sciences.

What sector and industry does Lobe Sciences (LOBEF) operate in?

Lobe Sciences is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQB.

Key Statistics

Open

$0.05

Volume / Avg.

2.54K / 105.32K

Day Range

$0.05 - $0.05

52 Wk Range

0.02 - 0.08

Market Cap

$13.78M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Lobe Sciences Ltd News

Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More

World's Largest Psychedelics Conference Boasts 12K Attendees

Lara Goldstein

This Biotech Is Entering The Clinical Stage With A Psilocin Analog Targeting Cluster Headaches

Lara Goldstein

Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More

Lara Goldstein

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-1.75M

Investing Cash Flow (TTM)

-1.03M

Financing Cash Flow (TTM)

8.81M

Free Cash Flow (TTM)

-1.75M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

6.03M

Valuation Metrics

Enterprise Value

$9.72M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

11.24

Earnings Yield % (TTM)

-61.73%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.00

Company Debt

Total Debt

$295.68K

LT Debt

$295.68K

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$5.99M

Debt to Equity

0.19

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.05

Volume / Avg.

2.54K / 105.32K

Day Range

$0.05 - $0.05

52 Wk Range

0.02 - 0.08

Market Cap

$13.78M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

N/A

Industry

N/A

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Lobe Sciences (LOBEF) stock?

You can purchase shares of Lobe Sciences (OTCQB:LOBEF) through any online brokerage.

View our list of the best stock brokerages

Who are Lobe Sciences (LOBEF) competitors?

There are no as such competitors for Lobe Sciences.

What is the forecast, or price target, for Lobe Sciences (LOBEF) stock?

There is no analysis for Lobe Sciences to provide a consensus price target.

What is the current price for Lobe Sciences (LOBEF)?

The stock price for Lobe Sciences (OTCQB: LOBEF) is $0.05112 last updated April 2, 2026 at 12:37 PM EDT.

Does Lobe Sciences (LOBEF) pay a dividend?

There are no upcoming dividends for Lobe Sciences.

When is Lobe Sciences (OTCQB:LOBEF) reporting earnings?

Lobe Sciences does not have any upcoming earnings scheduled.

Is Lobe Sciences (LOBEF) going to split?

There is no upcoming split for Lobe Sciences.

What sector and industry does Lobe Sciences (LOBEF) operate in?

Lobe Sciences is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQB.